Experienced in Endometritis

Weidong D. Zhao

Hefei, CN 
Experienced in Endometritis
Hefei, CN 
OverviewLocationsClinical Research

Overview

Weidong Zhao practices in Hefei, China. Zhao is rated as an Experienced expert by MediFind in the treatment of Endometritis. Their top areas of expertise are Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Lymphadenectomy, and Hysterectomy.

Their clinical research consists of co-authoring 99 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Endometritis.

Locations

Hefei, China
Other Locations
Nanjing, 211816, China
State Key Laboratory Of Polymer Science And Technology, Changchun, 130022, China
Guangdong, China
Chuzhou, 239000, China
Key Laboratory Of Analytical Chemistry For Living Biosystems, Beijing, 100049, China
Wuhu, China
Jinan, 250012, China
Ma'anshan, 243032, China
China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Open-label, Multicenter Phase II Study of TQB2450 Injection or Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
A Open-label, Multicenter Phase II Study of TQB2450 Injection or Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
Enrollment Status: Completed
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drugs: TQB2450, Anlotinib
Study Phase: Phase 2
A Phase II, Multicenter, Open Label Study of Bintrafusp Alfa (M7824) Monotherapy in Participants With Advanced, Unresectable Cervical Cancer With Disease Progression During or After Platinum-Containing Chemotherapy
A Phase II, Multicenter, Open Label Study of Bintrafusp Alfa (M7824) Monotherapy in Participants With Advanced, Unresectable Cervical Cancer With Disease Progression During or After Platinum-Containing Chemotherapy
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Bintrafusp Alfa
Study Phase: Phase 2
View 1 Less Clinical Trial

99 Total Publications

Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.
Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.
Journal: The New England journal of medicine
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhao's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile